Phase I trial of CTP 298 in patients with HIV infections.

Trial Profile

Phase I trial of CTP 298 in patients with HIV infections.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 27 Jun 2013

At a glance

  • Drugs CTP 298 (Primary)
  • Indications HIV infections
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 27 Jun 2013 Status changed from planning to discontinued, based on the June 2013 product pipeline of Concert Pharmaceuticals. It appears that the development of this agent has been discontinued.
    • 21 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top